,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1367603,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,POLI,https://www.dgidb.org/genes/POLI,,,11201,POLI,9606,Homo sapiens (human),,,,,,,,
1,1367604,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,ATG4B,https://www.dgidb.org/genes/ATG4B,,,23192,ATG4B,9606,Homo sapiens (human),,,,,,,,
2,1386226,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,ALOX15,https://www.dgidb.org/genes/ALOX15,,,246,ALOX15,9606,Homo sapiens (human),,,,,,,,
3,1445884,5280934,IUPHAR/BPS Guide to PHARMACOLOGY,Linolenic Acid,1049,α-linolenic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1049,225,FFA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=225,O14842,Free fatty acid receptor 1,2864,FFAR1,9606,Homo sapiens (human),Full agonist,pEC50,4.6 - 5.7,PMID:12496284|PMID:12565875|PMID:12629551,https://www.ncbi.nlm.nih.gov/pubmed/12496284|https://www.ncbi.nlm.nih.gov/pubmed/12565875|https://www.ncbi.nlm.nih.gov/pubmed/12629551,12496284|12565875|12629551,,
4,1447827,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,TDP1,https://www.dgidb.org/genes/TDP1,,,55775,TDP1,9606,Homo sapiens (human),,,,,,,,
5,1460059,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,POLK,https://www.dgidb.org/genes/POLK,,,51426,POLK,9606,Homo sapiens (human),,,,,,,,
6,1474071,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,ALDH1A1,https://www.dgidb.org/genes/ALDH1A1,,,216,ALDH1A1,9606,Homo sapiens (human),,,,,,,,
7,1474072,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,CYP3A4,https://www.dgidb.org/genes/CYP3A4,,,1576,CYP3A4,9606,Homo sapiens (human),,,,,,,,
8,1496666,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,RECQL,https://www.dgidb.org/genes/RECQL,,,5965,RECQL,9606,Homo sapiens (human),,,,,,,,
9,1496667,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,MAPT,https://www.dgidb.org/genes/MAPT,,,4137,MAPT,9606,Homo sapiens (human),,,,,,,,
10,1496795,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,NFE2L2,https://www.dgidb.org/genes/NFE2L2,,,4780,NFE2L2,9606,Homo sapiens (human),,,,,,,,
11,1517670,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,VDR,https://www.dgidb.org/genes/VDR,,,7421,VDR,9606,Homo sapiens (human),,,,,,,,
12,1551169,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,FFAR1,https://www.dgidb.org/genes/FFAR1,,,2864,FFAR1,9606,Homo sapiens (human),,,,PMID:19007110,https://www.ncbi.nlm.nih.gov/pubmed/19007110,19007110,,
13,1551170,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,HSD17B10,https://www.dgidb.org/genes/HSD17B10,,,3028,HSD17B10,9606,Homo sapiens (human),,,,,,,,
14,1608403,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,KAT2A,https://www.dgidb.org/genes/KAT2A,,,2648,KAT2A,9606,Homo sapiens (human),,,,,,,,
15,1608404,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,GLS,https://www.dgidb.org/genes/GLS,,,2744,GLS,9606,Homo sapiens (human),,,,,,,,
16,1608405,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,WRN,https://www.dgidb.org/genes/WRN,,,7486,WRN,9606,Homo sapiens (human),,,,,,,,
17,2012786,5280934,IUPHAR/BPS Guide to PHARMACOLOGY,Linolenic Acid,1049,α-linolenic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1049,127,FFA4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=127,Q5NUL3,Free fatty acid receptor 4,338557,FFAR4,9606,Homo sapiens (human),Full agonist,pEC50,5.5,PMID:22519963,https://www.ncbi.nlm.nih.gov/pubmed/22519963,22519963,,
18,2012787,5280934,IUPHAR/BPS Guide to PHARMACOLOGY,Linolenic Acid,1049,α-linolenic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1049,127,FFA4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=127,Q2AC31,Free fatty acid receptor 4,294075,Ffar4,10116,Rattus norvegicus (Norway rat),Full agonist,pEC50,5.06,PMID:18320172,https://www.ncbi.nlm.nih.gov/pubmed/18320172,18320172,,
19,2012788,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,ALOX15B,https://www.dgidb.org/genes/ALOX15B,,,247,ALOX15B,9606,Homo sapiens (human),,,,,,,,
20,2012789,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0000986,Sodium/calcium exchanger 1,https://www.drugbank.ca/bio_entities/BE0000986,P32418,Sodium/calcium exchanger 1,6546,SLC8A1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:17059813,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/17059813,17139284|17016423|17059813,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Ander BP, Hurtado C, Raposo CS, Maddaford TG, Deniset JF, Hryshko LV, Pierce GN, Lukas A: Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid. Cardiovasc Res. 2007 Jan 15;73(2):395-403. Epub 2006 Sep 23."
21,2012790,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0009375,Elongation of very long chain fatty acids protein 5,https://www.drugbank.ca/bio_entities/BE0009375,Q9NYP7,Elongation of very long chain fatty acids protein 5,60481,ELOVL5,9606,Homo sapiens (human),Substrate,,,PMID:30507367,https://www.ncbi.nlm.nih.gov/pubmed/30507367,30507367,,"Kim D, Choi JE, Park Y: Low-linoleic acid diet and oestrogen enhance the conversion of alpha-linolenic acid into DHA through modification of conversion enzymes and transcription factors. Br J Nutr. 2019 Jan;121(2):137-145. doi: 10.1017/S0007114518003252. Epub 2018 Dec 3."
22,2012791,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0000888,Fatty acid desaturase 1,https://www.drugbank.ca/bio_entities/BE0000888,O60427,Acyl-CoA (8-3)-desaturase,3992,FADS1,9606,Homo sapiens (human),Ligand,,,PMID:16988497|PMID:8673626|PMID:11518758|PMID:8487621|PMID:10765977,https://www.ncbi.nlm.nih.gov/pubmed/16988497|https://www.ncbi.nlm.nih.gov/pubmed/8673626|https://www.ncbi.nlm.nih.gov/pubmed/11518758|https://www.ncbi.nlm.nih.gov/pubmed/8487621|https://www.ncbi.nlm.nih.gov/pubmed/10765977,16988497|8673626|11518758|8487621|10765977,,"Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19.|Descomps B, Rodriguez A: [Essential fatty acids and prematurity: a triple experimental approach]. C R Seances Soc Biol Fil. 1995;189(5):781-96.|Hoffman DR, DeMar JC, Heird WC, Birch DG, Anderson RE: Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J Lipid Res. 2001 Sep;42(9):1395-401.|Maniongui C, Blond JP, Ulmann L, Durand G, Poisson JP, Bezard J: Age-related changes in delta 6 and delta 5 desaturase activities in rat liver microsomes. Lipids. 1993 Apr;28(4):291-7.|Mohan IK, Das UN: Effect of L-arginine-nitric oxide system on the metabolism of essential fatty acids in chemical-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2000 Jan;62(1):35-46."
23,2012802,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0002246,Fatty acid desaturase 2,https://www.drugbank.ca/bio_entities/BE0002246,O95864,Acyl-CoA 6-desaturase,9415,FADS2,9606,Homo sapiens (human),Ligand,,,PMID:17409318|PMID:16988497|PMID:17284757|PMID:15481543|PMID:12713571|PMID:21210105,https://www.ncbi.nlm.nih.gov/pubmed/17409318|https://www.ncbi.nlm.nih.gov/pubmed/16988497|https://www.ncbi.nlm.nih.gov/pubmed/17284757|https://www.ncbi.nlm.nih.gov/pubmed/15481543|https://www.ncbi.nlm.nih.gov/pubmed/12713571|https://www.ncbi.nlm.nih.gov/pubmed/21210105,17409318|16988497|17284757|15481543|12713571|21210105,,"Portolesi R, Powell BC, Gibson RA: Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res. 2007 Jul;48(7):1592-8. Epub 2007 Apr 4.|Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19.|Baylin A, Ruiz-Narvaez E, Kraft P, Campos H: alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am J Clin Nutr. 2007 Feb;85(2):554-60.|Li MC, Bu YP, Wang GK, Hu GW, Xing LJ: [Heteologous expression of Mortierella isabellina delta6 -fatty acid desaturase gene in soybean]. Yi Chuan Xue Bao. 2004 Aug;31(8):858-63.|Ge L, Gordon JS, Hsuan C, Stenn K, Prouty SM: Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity. J Invest Dermatol. 2003 May;120(5):707-14.|Tan L, Meesapyodsuk D, Qiu X: Molecular analysis of 6 desaturase and 6 elongase from Conidiobolus obscurus in the biosynthesis of eicosatetraenoic acid, a omega3 fatty acid with nutraceutical potentials. Appl Microbiol Biotechnol. 2011 Apr;90(2):591-601. doi: 10.1007/s00253-010-3060-y. Epub 2011 Jan 6."
24,2012803,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0001023,Transient receptor potential cation channel subfamily V member 1,https://www.drugbank.ca/bio_entities/BE0001023,Q8NER1,Transient receptor potential cation channel subfamily V member 1,7442,TRPV1,9606,Homo sapiens (human),Inhibitor,,,PMID:17038422,https://www.ncbi.nlm.nih.gov/pubmed/17038422,17038422,,"Matta JA, Miyares RL, Ahern GP: TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. J Physiol. 2007 Jan 15;578(Pt 2):397-411. Epub 2006 Oct 12."
25,2012804,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0000071,Peroxisome proliferator-activated receptor alpha,https://www.drugbank.ca/bio_entities/BE0000071,Q07869,Peroxisome proliferator-activated receptor alpha,5465,PPARA,9606,Homo sapiens (human),,,,PMID:10403814|PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/10403814|https://www.ncbi.nlm.nih.gov/pubmed/16731579,10403814|16731579,,"Murakami K, Ide T, Suzuki M, Mochizuki T, Kadowaki T: Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13.|Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26."
26,2012805,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0001777,Bile acid receptor,https://www.drugbank.ca/bio_entities/BE0001777,Q96RI1,Bile acid receptor,9971,NR1H4,9606,Homo sapiens (human),Agonist,,,PMID:21658928,https://www.ncbi.nlm.nih.gov/pubmed/21658928,21658928,,"Zhang J, Kris-Etherton PM, Thompson JT, Hannon DB, Gillies PJ, Heuvel JP: Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action. J Nutr Biochem. 2012 Apr;23(4):400-9. doi: 10.1016/j.jnutbio.2011.01.004. Epub 2011 Jun 11."
27,2012806,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0001007,Peroxisome proliferator-activated receptor delta,https://www.drugbank.ca/bio_entities/BE0001007,Q03181,Peroxisome proliferator-activated receptor delta,5467,PPARD,9606,Homo sapiens (human),,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,"Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26."
28,2012807,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0000215,Peroxisome proliferator-activated receptor gamma,https://www.drugbank.ca/bio_entities/BE0000215,P37231,Peroxisome proliferator-activated receptor gamma,5468,PPARG,9606,Homo sapiens (human),,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,"Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26."
29,2012808,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0000412,Retinoic acid receptor RXR-alpha,https://www.drugbank.ca/bio_entities/BE0000412,P19793,Retinoic acid receptor RXR-alpha,6256,RXRA,9606,Homo sapiens (human),,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,"Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26."
30,2012809,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0001821,"Fatty acid-binding protein, brain",https://www.drugbank.ca/bio_entities/BE0001821,O15540,"Fatty acid-binding protein, brain",2173,FABP7,9606,Homo sapiens (human),,,,PMID:10854433,https://www.ncbi.nlm.nih.gov/pubmed/10854433,10854433,,"Balendiran GK, Schnutgen F, Scapin G, Borchers T, Xhong N, Lim K, Godbout R, Spener F, Sacchettini JC: Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem. 2000 Sep 1;275(35):27045-54."
31,2012810,5280934,DrugBank,Linolenic Acid,DB00132,alpha-Linolenic acid,https://www.drugbank.ca/drugs/DB00132,BE0009936,Elongation of very long chain fatty acids protein 2,https://www.drugbank.ca/bio_entities/BE0009936,Q9NXB9,Elongation of very long chain fatty acids protein 2,54898,ELOVL2,9606,Homo sapiens (human),Substrate,,,PMID:30507367,https://www.ncbi.nlm.nih.gov/pubmed/30507367,30507367,,"Kim D, Choi JE, Park Y: Low-linoleic acid diet and oestrogen enhance the conversion of alpha-linolenic acid into DHA through modification of conversion enzymes and transcription factors. Br J Nutr. 2019 Jan;121(2):137-145. doi: 10.1017/S0007114518003252. Epub 2018 Dec 3."
32,2030322,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,10090,Mus musculus (house mouse),Alpha-linolenic acid results in increased expression of PPARG mRNA,,,PMID:18154422,https://www.ncbi.nlm.nih.gov/pubmed/18154422,18154422,,
33,2030323,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578,PRKCA,10029,Cricetulus griseus (Chinese hamster),Alpha-linolenic acid affects the localization of PRKCA protein,,,PMID:23285216,https://www.ncbi.nlm.nih.gov/pubmed/23285216,23285216,,
34,2030324,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647,ABCB11,9606,Homo sapiens (human),Alpha-linolenic acid promotes the reaction [GW 4064 results in increased expression of ABCB11 mrna],,,PMID:15307955,https://www.ncbi.nlm.nih.gov/pubmed/15307955,15307955,,
35,2030325,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in decreased expression of ACACA mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
36,2030326,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47,ACLY,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in decreased expression of ACLY mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
37,2030327,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590,BCHE,9606,Homo sapiens (human),Alpha-linolenic acid results in increased secretion of BCHE protein|alpha-linolenic acid results in increased expression of BCHE mRNA,,,PMID:27106529,https://www.ncbi.nlm.nih.gov/pubmed/27106529,27106529,,
38,2030328,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [methylmercuric chloride results in decreased activity of CAT protein],,,PMID:22269903,https://www.ncbi.nlm.nih.gov/pubmed/22269903,22269903,,
39,2030329,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347,CCL2,10116,Rattus norvegicus (Norway rat),"Particulate matter inhibits the reaction [alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of CCL2 protein]]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of CCL2 mrna]]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of CCL2 protein]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of CCL2 protein]]",,,PMID:29423081,https://www.ncbi.nlm.nih.gov/pubmed/29423081,29423081,,
40,2030330,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051,CEBPB,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in decreased expression of CEBPB mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
41,2030331,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374,CPT1A,9606,Homo sapiens (human),Alpha-linolenic acid results in increased expression of CPT1A mRNA,,,PMID:15307955,https://www.ncbi.nlm.nih.gov/pubmed/15307955,15307955,,
42,2030332,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536,CYBB,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [[cholesterol co-treated with particulate matter] results in increased expression of CYBB protein],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
43,2030333,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544,CYP1A2,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of CYP1A2 protein,,,PMID:16978661,https://www.ncbi.nlm.nih.gov/pubmed/16978661,16978661,,
44,2030334,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1591,CYP24A1,https://ctdbase.org/detail.go?type=gene&acc=1591,,,1591,CYP24A1,9606,Homo sapiens (human),Alpha-linolenic acid inhibits the reaction [calcitriol results in increased expression of CYP24A1 mrna],,,PMID:19667161,https://www.ncbi.nlm.nih.gov/pubmed/19667161,19667161,,
45,2030335,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548,CYP2A6,9606,Homo sapiens (human),NFE2L2 protein promotes the reaction [alpha-linolenic acid results in increased expression of CYP2A6 mrna]|alpha-linolenic acid results in increased expression of CYP2A6 protein|alpha-linolenic acid results in increased expression of CYP2A6 mrna|nfe2l2 protein promotes the reaction [alpha-linolenic acid results in increased expression of CYP2A6 protein],,,PMID:28555106,https://www.ncbi.nlm.nih.gov/pubmed/28555106,28555106,,
46,2030336,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557,CYP2C19,9606,Homo sapiens (human),CYP2C19 protein results in increased metabolism of [alpha-linolenic acid co-treated with nadp]|alpha-linolenic acid results in decreased activity of CYP2C19 protein,,,PMID:16978661,https://www.ncbi.nlm.nih.gov/pubmed/16978661,16978661,,
47,2030337,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559,CYP2C9,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of CYP2C9 protein|cyp2c9 protein results in increased metabolism of [alpha-linolenic acid co-treated with NADP],,,PMID:16978661,https://www.ncbi.nlm.nih.gov/pubmed/16978661,16978661,,
48,2030338,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571,CYP2E1,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of CYP2E1 protein,,,PMID:16978661,https://www.ncbi.nlm.nih.gov/pubmed/16978661,16978661,,
49,2030339,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of CYP3A4 protein,,,PMID:16978661,https://www.ncbi.nlm.nih.gov/pubmed/16978661,16978661,,
50,2030340,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733,DIO1,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of DIO1 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
51,2030341,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734,DIO2,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of DIO2 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
52,2030342,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735,DIO3,9606,Homo sapiens (human),Alpha-linolenic acid results in decreased activity of DIO3 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
53,2030343,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3992,FADS1,https://ctdbase.org/detail.go?type=gene&acc=3992,,,3992,FADS1,9606,Homo sapiens (human),"Fulvestrant inhibits the reaction [[alpha-linolenic acid co-treated with estradiol] results in increased expression of FADS1 mrna]|[[alpha-linolenic acid co-treated with testosterone] results in decreased expression of FADS1 mrna] which affects the abundance of fatty acids, unsaturated|[alpha-linolenic acid co-treated with testosterone] results in decreased expression of FADS1 mrna|[alpha-linolenic acid co-treated with estradiol] results in increased expression of FADS1 mrna|[[alpha-linolenic acid co-treated with estradiol] results in increased expression of FADS1 mrna] which affects the abundance of fatty acids, unsaturated",,,PMID:19576517,https://www.ncbi.nlm.nih.gov/pubmed/19576517,19576517,,
54,2030344,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194,FASN,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in decreased expression of FASN mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
55,2030345,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729,GCLC,9606,Homo sapiens (human),Alpha-linolenic acid results in increased activity of GCLC protein|alpha-linolenic acid results in increased expression of GCLC mRNA,,,PMID:17092368,https://www.ncbi.nlm.nih.gov/pubmed/17092368,17092368,,
56,2030346,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875,GPT,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [methylmercuric chloride results in increased activity of GPT protein],,,PMID:22269903,https://www.ncbi.nlm.nih.gov/pubmed/22269903,22269903,,
57,2030347,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938,GSTA1,9606,Homo sapiens (human),Alpha-linolenic acid results in increased expression of GSTA1 mrna|nfe2l2 protein promotes the reaction [alpha-linolenic acid results in increased expression of GSTA1 mrna],,,PMID:28555106,https://www.ncbi.nlm.nih.gov/pubmed/28555106,28555106,,
58,2030348,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,9606,Homo sapiens (human),Alpha-linolenic acid results in increased expression of HMOX1 mRNA,,,PMID:17092368,https://www.ncbi.nlm.nih.gov/pubmed/17092368,17092368,,
59,2030349,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [cholesterol results in increased expression of HMOX1 mrna]],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
60,2030350,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [[cholesterol co-treated with particulate matter] results in increased expression of IFNG protein],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
61,2030351,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,10116,Rattus norvegicus (Norway rat),"Alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IFNG mrna]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IFNG mrna]]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IFNG protein]]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IFNG protein]",,,PMID:29423081,https://www.ncbi.nlm.nih.gov/pubmed/29423081,29423081,,
62,2030352,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),[eicosapentaenoic acid co-treated with docosahexaenoic acids co-treated with alpha-linolenic acid] results in increased expression of IL1B protein,,,PMID:16305726,https://www.ncbi.nlm.nih.gov/pubmed/16305726,16305726,,
63,2030353,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [[cholesterol co-treated with particulate matter] results in increased expression of IL1B protein],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
64,2030354,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565,IL4,9606,Homo sapiens (human),[eicosapentaenoic acid co-treated with docosahexaenoic acids co-treated with alpha-linolenic acid] results in decreased expression of IL4 protein,,,PMID:16305726,https://www.ncbi.nlm.nih.gov/pubmed/16305726,16305726,,
65,2030355,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),"Alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IL6 mrna]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IL6 protein]]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IL6 protein]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IL6 mrna]]|particulate matter inhibits the reaction [alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of IL6 mrna]]",,,PMID:29423081,https://www.ncbi.nlm.nih.gov/pubmed/29423081,29423081,,
66,2030356,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [cholesterol promotes the reaction [particulate matter results in increased expression of IL6 protein]],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
67,2030357,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,3827,KNG1,https://ctdbase.org/detail.go?type=gene&acc=3827,,,3827,KNG1,9606,Homo sapiens (human),Alpha-linolenic acid inhibits the reaction [GW 4064 results in increased expression of KNG1 mrna],,,PMID:15307955,https://www.ncbi.nlm.nih.gov/pubmed/15307955,15307955,,
68,2030358,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780,NFE2L2,9606,Homo sapiens (human),NFE2L2 protein promotes the reaction [alpha-linolenic acid results in increased expression of CYP2A6 mrna]|nfe2l2 protein promotes the reaction [alpha-linolenic acid results in increased expression of GSTA1 mrna]|nfe2l2 protein promotes the reaction [alpha-linolenic acid results in increased expression of CYP2A6 protein],,,PMID:28555106,https://www.ncbi.nlm.nih.gov/pubmed/28555106,28555106,,
69,2030359,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780,NFE2L2,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [cholesterol promotes the reaction [particulate matter results in increased expression of NFE2L2 mrna]]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [cholesterol results in increased expression of NFE2L2 mrna]]|alpha-linolenic acid inhibits the reaction [cholesterol results in increased expression of NFE2L2 mrna],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
70,2030360,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843,NOS2,10116,Rattus norvegicus (Norway rat),"Alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of NOS2 protein]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of NOS2 mrna]]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of NOS2 protein]]|particulate matter inhibits the reaction [alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of NOS2 protein]]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of NOS2 mrna]|particulate matter inhibits the reaction [alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of NOS2 mrna]]",,,PMID:29423081,https://www.ncbi.nlm.nih.gov/pubmed/29423081,29423081,,
71,2030361,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [cholesterol results in increased expression of NQO1 mrna]],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
72,2030362,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376,NR1H2,10090,Mus musculus (house mouse),Alpha-linolenic acid binds to and results in increased activity of NR1H2 protein,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
73,2030363,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971,NR1H4,9606,Homo sapiens (human),Alpha-linolenic acid inhibits the reaction [chenodeoxycholic acid results in increased activity of NR1H4 protein]|alpha-linolenic acid binds to NR1H4 protein,,,PMID:15307955,https://www.ncbi.nlm.nih.gov/pubmed/15307955,15307955,,
74,2030364,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105,PCK1,10090,Mus musculus (house mouse),[glucose deficiency co-treated with alpha-linolenic acid] results in increased expression of PCK1 mRNA,,,PMID:8536680,https://www.ncbi.nlm.nih.gov/pubmed/8536680,8536680,,
75,2030365,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123,PLIN2,10090,Mus musculus (house mouse),Alpha-linolenic acid results in increased expression of PLIN2 mrna|alpha-linolenic acid results in increased expression of PLIN2 protein,,,PMID:16489205,https://www.ncbi.nlm.nih.gov/pubmed/16489205,16489205,,
76,2030366,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,9606,Homo sapiens (human),Alpha-linolenic acid binds to and results in increased activity of PPARA protein,,,PMID:10403814|PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/10403814|https://www.ncbi.nlm.nih.gov/pubmed/16731579,10403814|16731579,,
77,2030367,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,9606,Homo sapiens (human),Calcitriol promotes the reaction [alpha-linolenic acid results in increased expression of PPARA mrna]|alpha-linolenic acid results in increased expression of PPARA mRNA,,,PMID:19667161,https://www.ncbi.nlm.nih.gov/pubmed/19667161,19667161,,
78,2030368,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,10090,Mus musculus (house mouse),Alpha-linolenic acid binds to and results in increased activity of PPARA protein,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
79,2030369,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,10090,Mus musculus (house mouse),Alpha-linolenic acid results in increased expression of PPARA mRNA,,,PMID:18154422,https://www.ncbi.nlm.nih.gov/pubmed/18154422,18154422,,
80,2030370,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,10090,Mus musculus (house mouse),Diethylhexyl phthalate inhibits the reaction [PPARA protein affects the abundance of alpha-linolenic acid]|ppara protein affects the abundance of alpha-linolenic acid,,,PMID:23619606,https://www.ncbi.nlm.nih.gov/pubmed/23619606,23619606,,
81,2030371,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,100136658,PPARB,https://ctdbase.org/detail.go?type=gene&acc=100136658,,,100136658,,9606,Homo sapiens (human),Alpha-linolenic acid binds to and results in increased activity of PPARB protein,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
82,2030372,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467,PPARD,9606,Homo sapiens (human),Calcitriol results in increased expression of [alpha-linolenic acid results in increased expression of PPARD mrna]|alpha-linolenic acid results in increased expression of PPARD mRNA,,,PMID:19667161,https://www.ncbi.nlm.nih.gov/pubmed/19667161,19667161,,
83,2030373,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9606,Homo sapiens (human),Alpha-linolenic acid binds to and results in increased activity of PPARG protein,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
84,2030374,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Alpha-linolenic acid results in increased expression of PTGS2 mRNA,,,PMID:17092368,https://www.ncbi.nlm.nih.gov/pubmed/17092368,17092368,,
85,2030375,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in decreased expression of PTGS2 mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
86,2030376,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in increased expression of PTGS2 protein,,,PMID:22476691,https://www.ncbi.nlm.nih.gov/pubmed/22476691,22476691,,
87,2030377,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9823,Sus scrofa (pig),Alpha-linolenic acid inhibits the reaction [[polychlorinated biphenyls results in increased activity of PTGS2 protein] which results in increased chemical synthesis of dinoprostone]|alpha-linolenic acid inhibits the reaction [polychlorinated biphenyls results in increased expression of PTGS2 mrna]|alpha-linolenic acid inhibits the reaction [polychlorinated biphenyls results in increased expression of PTGS2 protein],,,PMID:18155686,https://www.ncbi.nlm.nih.gov/pubmed/18155686,18155686,,
88,2030378,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256,RXRA,9606,Homo sapiens (human),Alpha-linolenic acid binds to and results in increased activity of RXRA protein,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
89,2030379,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256,RXRA,9606,Homo sapiens (human),Alpha-linolenic acid binds to RXRA protein,,,PMID:16258897,https://www.ncbi.nlm.nih.gov/pubmed/16258897,16258897,,
90,2030380,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720,SREBF1,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in decreased expression of SREBF1 mRNA,,,PMID:14563831,https://www.ncbi.nlm.nih.gov/pubmed/14563831,14563831,,
91,2030381,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),"Alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of TNF protein]]|particulate matter inhibits the reaction [alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of TNF protein]]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of TNF protein]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of TNF mrna]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of TNF mrna]]",,,PMID:29423081,https://www.ncbi.nlm.nih.gov/pubmed/29423081,29423081,,
92,2030382,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [cholesterol promotes the reaction [particulate matter results in increased expression of TNF protein]],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
93,2030383,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442,TRPV1,10116,Rattus norvegicus (Norway rat),"[alpha-linolenic acid co-treated with phorbol 12,13-dibutyrate] results in increased activity of TRPV1 protein",,,PMID:17038422,https://www.ncbi.nlm.nih.gov/pubmed/17038422,17038422,,
94,2030384,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351,UCP2,10116,Rattus norvegicus (Norway rat),Alpha-linolenic acid results in increased expression of UCP2 mRNA,,,PMID:11341955,https://www.ncbi.nlm.nih.gov/pubmed/11341955,11341955,,
95,2030385,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412,VCAM1,10116,Rattus norvegicus (Norway rat),"Alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of VCAM1 mrna]|alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of VCAM1 protein]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of VCAM1 protein]]|particulate matter inhibits the reaction [alpha-linolenic acid inhibits the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of VCAM1 protein]]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [[cholesterol, dietary co-treated with NG-nitroarginine methyl ester] results in increased expression of VCAM1 mrna]]",,,PMID:29423081,https://www.ncbi.nlm.nih.gov/pubmed/29423081,29423081,,
96,2030386,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412,VCAM1,9823,Sus scrofa (pig),Alpha-linolenic acid inhibits the reaction [polychlorinated biphenyls results in increased expression of VCAM1 protein]|alpha-linolenic acid inhibits the reaction [polychlorinated biphenyls results in increased expression of VCAM1 mrna],,,PMID:18155686,https://www.ncbi.nlm.nih.gov/pubmed/18155686,18155686,,
97,2030387,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421,VDR,9606,Homo sapiens (human),Alpha-linolenic acid results in increased expression of VDR mrna|[calcitriol co-treated with alpha-linolenic acid] results in increased expression of VDR mRNA,,,PMID:19667161,https://www.ncbi.nlm.nih.gov/pubmed/19667161,19667161,,
98,2030388,5280934,Comparative Toxicogenomics Database (CTD),Linolenic Acid,D017962,alpha-Linolenic Acid,https://ctdbase.org/detail.go?type=chem&acc=D017962,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9606,Homo sapiens (human),Alpha-linolenic acid results in increased activity of PPARG protein,,,PMID:20696231,https://www.ncbi.nlm.nih.gov/pubmed/20696231,20696231,,
99,2030389,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0002246,Fatty acid desaturase 2,http://www.t3db.ca/biodb/bio_entities/BE0002246,O95864,Acyl-CoA 6-desaturase,9415,FADS2,9606,Homo sapiens (human),,,,PMID:16988497|PMID:17409318|PMID:17284757|PMID:15481543|PMID:12713571|PMID:21210105,https://www.ncbi.nlm.nih.gov/pubmed/16988497|https://www.ncbi.nlm.nih.gov/pubmed/17409318|https://www.ncbi.nlm.nih.gov/pubmed/17284757|https://www.ncbi.nlm.nih.gov/pubmed/15481543|https://www.ncbi.nlm.nih.gov/pubmed/12713571|https://www.ncbi.nlm.nih.gov/pubmed/21210105,16988497|17409318|17284757|15481543|12713571|21210105,,
100,2030390,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000888,Fatty acid desaturase 1,http://www.t3db.ca/biodb/bio_entities/BE0000888,O60427,Acyl-CoA (8-3)-desaturase,3992,FADS1,9606,Homo sapiens (human),,,,PMID:16988497|PMID:8673626|PMID:11518758|PMID:8487621|PMID:10765977,https://www.ncbi.nlm.nih.gov/pubmed/16988497|https://www.ncbi.nlm.nih.gov/pubmed/8673626|https://www.ncbi.nlm.nih.gov/pubmed/11518758|https://www.ncbi.nlm.nih.gov/pubmed/8487621|https://www.ncbi.nlm.nih.gov/pubmed/10765977,16988497|8673626|11518758|8487621|10765977,,
101,2030391,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000986,Sodium/calcium exchanger 1,http://www.t3db.ca/biodb/bio_entities/BE0000986,P32418,Sodium/calcium exchanger 1,6546,SLC8A1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:17059813,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/17059813,17139284|17016423|17059813,,
102,2030392,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0002247,Elongation of very long chain fatty acids protein 4,http://www.t3db.ca/biodb/bio_entities/BE0002247,Q9GZR5,Elongation of very long chain fatty acids protein 4,6785,ELOVL4,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
103,2030393,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000071,Peroxisome proliferator-activated receptor alpha,http://www.t3db.ca/biodb/bio_entities/BE0000071,Q07869,Peroxisome proliferator-activated receptor alpha,5465,PPARA,9606,Homo sapiens (human),,,,PMID:10403814|PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/10403814|https://www.ncbi.nlm.nih.gov/pubmed/16731579,10403814|16731579,,
104,2030394,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0001023,Transient receptor potential cation channel subfamily V member 1,http://www.t3db.ca/biodb/bio_entities/BE0001023,Q8NER1,Transient receptor potential cation channel subfamily V member 1,7442,TRPV1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
105,2030395,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0001777,Bile acid receptor,http://www.t3db.ca/biodb/bio_entities/BE0001777,Q96RI1,Bile acid receptor,9971,NR1H4,9606,Homo sapiens (human),,,,PMID:15307955,https://www.ncbi.nlm.nih.gov/pubmed/15307955,15307955,,
106,2030396,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0001007,Peroxisome proliferator-activated receptor delta,http://www.t3db.ca/biodb/bio_entities/BE0001007,Q03181,Peroxisome proliferator-activated receptor delta,5467,PPARD,9606,Homo sapiens (human),,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
107,2030397,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000215,Peroxisome proliferator-activated receptor gamma,http://www.t3db.ca/biodb/bio_entities/BE0000215,P37231,Peroxisome proliferator-activated receptor gamma,5468,PPARG,9606,Homo sapiens (human),,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
108,2030398,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856,NR1I2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
109,2030399,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099,ESR1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
110,2030400,5280934,Toxin and Toxin Target Database (T3DB),Linolenic Acid,T3D4812,Alpha-Linolenic Acid,http://www.t3db.ca/toxins/T3D4812,BE0000412,Retinoic acid receptor RXR-alpha,http://www.t3db.ca/biodb/bio_entities/BE0000412,P19793,Retinoic acid receptor RXR-alpha,6256,RXRA,9606,Homo sapiens (human),,,,PMID:16731579,https://www.ncbi.nlm.nih.gov/pubmed/16731579,16731579,,
111,2030401,5280934,Therapeutic Target Database (TTD),Linolenic Acid,D0C5SV,alpha-linolenic acid,https://idrblab.net/ttd/data/drug/details/D0C5SV,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743,PTGS2,9606,Homo sapiens (human),Inhibitor,,,,,,,
112,2037453,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,EHMT2,https://www.dgidb.org/genes/EHMT2,,,10919,EHMT2,9606,Homo sapiens (human),,,,,,,,
113,2037454,5280934,Drug Gene Interaction database (DGIdb),Linolenic Acid,,LINOLENIC ACID,https://www.dgidb.org/drugs/LINOLENIC ACID,,POLH,https://www.dgidb.org/genes/POLH,,,5429,POLH,9606,Homo sapiens (human),,,,,,,,
114,2037455,5280934,Therapeutic Target Database (TTD),Linolenic Acid,D0C5SV,alpha-linolenic acid,https://idrblab.net/ttd/data/drug/details/D0C5SV,T25608,Free fatty acid receptor 1 (GPR40),https://idrblab.net/ttd/data/target/details/T25608,O14842,Free fatty acid receptor 1,2864,FFAR1,9606,Homo sapiens (human),Agonist,,,,,,,
115,2037456,5280934,Therapeutic Target Database (TTD),Linolenic Acid,D0C5SV,alpha-linolenic acid,https://idrblab.net/ttd/data/drug/details/D0C5SV,T51385,G-protein coupled receptor 120 (GPR120),https://idrblab.net/ttd/data/target/details/T51385,Q5NUL3,Free fatty acid receptor 4,338557,FFAR4,9606,Homo sapiens (human),Agonist,,,,,,,
